• 22/09/2022

    The Netherlands contributes € 180 million to end tuberculosis, HIV and malaria

    The Netherlands is contributing €180 million to the worldwide fight against tuberculosis (TB), HIV/AIDS and malaria. Minister Liesje Schreinemacher of…

    Lees meer

  • 05/08/2022

    KNCV is excited to join the USAID-funded, Johns Hopkins Medicine-led SMART4TB project

    With an investment of $200 million from USAID, Johns Hopkins Medicine launches the Supporting, Mobilizing and Accelerating Research…

    Lees meer

  • 08/04/2022

    Webinar: What’s next for Global Health in the wake of the pandemic?

    The Clingendael Institute organizes a series of online events regarding the complexities around the future of…

    Lees meer

  • 24/03/2022

    New LIFT-TB website highlights efforts to transform TB therapy amidst resurgence during COVID-19 pandemic

    The world continues to battle against two pandemics: COVID-19 and tuberculosis (TB). TB had long been the deadliest infectious disease—until…

    Lees meer

  • 24/03/2022

    ASCENT project: invest in innovative digital tools to end TB

    The Unitaid-funded ASCENT project has entered its final year and is well on its way in showing the benefits…

    Lees meer

  • 24/03/2022

    TREATS releases final report

    The TREATS (Tuberculosis Reduction through Expanded Antiretroviral Treatment and Screening for Active TB) project has just released its…

    Lees meer

  • 24/03/2022

    IMPAACT4TB raises awareness and access to TB Preventative Treatment

    About a quarter of the world’s population is infected with Mycobacterium Tuberculosis and thus at risk of developing tuberculosis (TB)…

    Lees meer

  • 24/03/2022

    KardiaMobile for ECG monitoring: Innovative approach to help DR-TB patients in Kazakhstan

    KNCV is constantly looking for innovative approaches for patient-centered care. Patients with drug resistant tuberculosis (DR-TB) who receive treatment with…

    Lees meer

  • 04/03/2022

    Save the date: Wolfheze Workshops 2022

    Regaining lost ground: ending TB in Europe 16th WHO National TB Programme Managers’ Meeting and 20th Wolfheze Workshops…

    Lees meer

  • 28/02/2022

    New platform on digital adherence technologies for tuberculosis treatment

    As a part of the Global digital adherence technology (DAT) Task Force, KNCV Tuberculosis Foundation is pleased to announce the…

    Lees meer

  • 21/02/2022

    Dr. Bakyt Myrzaliev receives ‘Award for Partnership to End TB’

    Dr. Bakyt Myrzaliev, KNCV representative in Kyrgyzstan, has been awarded the ‘Award for Partnership to End TB’ by the…

    Lees meer

  • 24/01/2022

    Our sincere condolences for the passing of Dr. Lucie Blok

    The world of public health has lost a great colleague with a passion for teaching and quality public health response,…

    Lees meer

  • 24/01/2022

    Rest in peace, Dr. Baba Awe

    TB Program Nigeria, Afrika and the world will greatly miss the dedicated and passionate Dr. Baba Awe. He has spent…

    Lees meer

  • 21/01/2022

    Success for AMR Global with ‘GLORIA’

    AMR-Global has successfully secured co-funding from the PPP Allowance made available by Health~Holland, Top Sector Life Sciences & Health,…

    Lees meer

  • 10/12/2021

    Optimized models of care for TB prevention among migrants

    On Tuesday, 7 December 2021, the symposium “TB prevention among high-risk migrants in low-burden countries” was held online. The symposium…

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Ghana
Indonesia
Kazachstan
Kenya
Kyrgyzstan
Malawi
Namibia
Nigeria
Rwanda
South Africa
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Technical Assistance Strategy

New drugs & treatment regimens
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centred Framework for National Strategic Planning and HSS
Blended learning platform & methodologies

ASCENT
ASTTIE
Development of a comprehensive Digital Training Package
E-detect
GeneXpert MTB/RIF Test
IMPAACT4TB
PAVIA
People-Centered Framework for TB Programming
PODTEC
TB Alliance BPAL Project
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TREATS

Our success stories

Challenge TB
Improved TB/HIV Prevention & Care – Building Models for the Future Project
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

Annual Report 2020
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.